Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gallbladder Neoplasms × Ondansetron × Clear all

Sponsor

Conditions

Vomiting 12 Nausea 12 Neoplasms 5 Leukemia, Myeloid, Acute 4 Breast Neoplasms 4 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Burkitt Lymphoma 3 Testicular Neoplasms 2 Sezary Syndrome 2 Primary Myelofibrosis 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pdgfra-Associated Chronic Eosinophilic Leukemia 2 Neuroblastoma 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Neutrophilic, Chronic 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Myeloid, Accelerated Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell 2

Interventions

Gemcitabine 18 Cisplatin 10 Capecitabine 9 Oxaliplatin 6 pembrolizumab 4 Fluorouracil 4 Sorafenib 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Erlotinib Hydrochloride 3 trifluridine tipiracil drug combination 2 regorafenib 2 cobimetinib 2 atezolizumab 2 Trastuzumab 2 Taxes 2 Specimen Handling 2 Platinum 2 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2 Lapatinib 2 Biopsy 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 zanidatamab 1 varlilumab 1 vandetanib 1 tucatinib 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡